The European Society for Medical Oncology (ESMO) is pleased to announce the publication of the latest version of the scale that measures the clinical benefit of cancer treatments, the ESMO-MCBS ...

Prognostic impact of PSA nadir (n) ≥0.1 ng/mL within 6 months (m) after completion of radiotherapy (RT) for localized prostate cancer (PCa): An individual patient-data (IPD) analysis of randomized ...

Social Security tables and calculators leveraging data from the National Institutes of Health are available online to estimate a patient’s life expectancy to better understand a patient’s non–prostate ...

Partner presentations reinforce ability of proprietary AzymetricTM platform to develop clinically validated therapeutic antibodies <li ...

Clear signs of immune activation : ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune cascade, supporting its role in enhancing Aza-Ven efficacy, and ...

Prostate cancer usually does not cause symptoms in the early stages. Signs of prostate cancer can include frequent urination, weak or interrupted urine stream, painful ejaculation, blood in urine ...

One in eight men will be diagnosed with prostate cancer—and if you live long enough, chances of an enlarged prostate skyrocket. Experts weigh in on what you need to know. Hormonal changes in a ...

When Al Roker shared that he'd been diagnosed with prostate cancer in late September, he mentioned an eye-opening statistic: 1 in 9 men will be diagnosed in their lifetime, and for Black men that ...

(UroToday.com) The American Urologic Association (AUA) 2025 Annual Meeting held in Las Vegas, NV between April 26 th and 29 th, 2025 was host to The International Prostate Forum ... Division of Cancer ...